Skip to main content

Table 2 Baseline characteristics of febrile children with uncomplicated falciparum malaria enrolled in artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) groups

From: Malaria burden and anti-malarial drug efficacy in Owando, northern Congo

Characteristics Treatment group
ASAQ AL
No. of included patients 62 61
Age (months), mean ± SD (range) 71.0 ± 31.8 (9–132) 57.3 ± 30.4 (6–132)
<60 months (<5 years): N; % (95 % CI) 19; 30.6 (19.6–43.7) 29; 47.5 (34.6–60.7)
60–132 months (5–11 years): N; % (95 % CI) 43; 69.4 (56.3–80.4) 32; 52.5 (39.3–65.4)
Weight (kg), mean ± SD (range) 19.9 ± 7.8 (9–57) 18.1 ± 7.8 (7–44)
Sex ratio (F/M) 0.94 (30/32) 1.26 (34/27)
Axillary temperature, mean ± SD (range) (°C) 37.9 ± 1.0 (36.0–40.0) 38.0 ± 1.0 (36.0–40.4)
Parasite density (asexual parasites/µL)
 Geometric mean (range) 37,600 (1550–955,000) 34,200 (1000–700,000)
Self-medication before consultation: N; % (95 % CI) 0; 0 (0–5.8) 3; 4.9 (1.0–13.7)
Haematocrit, mean ± SD (%) 32.9 ± 5.0 31.9 ± 5.4
  1. There was a significant difference (p = 0.01) in age between the two treatment groups
  2. SD standard deviation, 95 % CI 95 % confidence interval